Edition:
United States

Tandem Diabetes Care Inc (TNDM.OQ)

TNDM.OQ on NASDAQ Stock Exchange Global Market

2.53USD
20 Oct 2017
Change (% chg)

$0.13 (+5.42%)
Prev Close
$2.40
Open
$2.40
Day's High
$2.66
Day's Low
$2.28
Volume
290,578
Avg. Vol
52,309
52-wk High
$70.00
52-wk Low
$2.28

Chart for

About

Tandem Diabetes Care, Inc. is a medical device company. The Company is engaged in designing, developing and commercializing products for people with insulin-dependent diabetes. The Company manufactures and sells three insulin pump products, which include t:slim Insulin Delivery System (t:slim), t:flex Insulin Delivery System... (more)

Overall

Beta: 0.08
Market Cap(Mil.): $25.60
Shares Outstanding(Mil.): 10.12
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 33.06 16.52
EPS (TTM): -- -- --
ROI: -- 13.87 11.32
ROE: -- 16.68 15.18

BRIEF-Empery Asset Management reports 5.63 pct passive stake in Tandem Diabetes Care

* Empery Asset Management Lp reports 5.63 pct passive stake in Tandem Diabetes Care Inc as of Oct 13 - SEC filing‍​ Source text: (http://bit.ly/2hSFBfg) Further company coverage:

Oct 20 2017

BRIEF-Tandem Diabetes Care sees Q3 sales of about $26.5 mln to $27.5 mln

* Sees Q3 sales about $26.5 million to $27.5 million - sec filing

Oct 13 2017

BRIEF-Tandem Diabetes Care announces proposed public offering of common stock

* Tandem Diabetes Care announces proposed underwritten public offering of common stock, Series A warrants and Series B warrants Source text for Eikon: Further company coverage:

Oct 12 2017

BRIEF-Tandem Diabetes Care‍ shareholders approv reverse stock split

* Tandem Diabetes Care Inc- ‍ shareholders subsequently approved reverse stock split at a ratio of 1-for-10​ Source text for Eikon: Further company coverage:

Oct 09 2017

BRIEF-Tandem Diabetes Care announces FDA approval, launch of t:slim X2 insulin pump with Dexcom G5 mobile CGM integration

* Tandem Diabetes care announces FDA approval and launch of t:slim X2 insulin pump with Dexcom G5 mobile CGM integration

Aug 28 2017

BRIEF-Tandem Diabetes Care announces issuance of patent related to remote bolus feature for medical infusion pumps

* Tandem Diabetes Care announces issuance of patent related to remote bolus feature for medical infusion pumps Source text for Eikon: Further company coverage:

Aug 24 2017

BRIEF-Tandem Diabetes Care begins enrollment for 1st touchscreen insulin pump with PGLS

* Tandem Diabetes Care begins enrollment in pivotal trial for first touchscreen insulin pump with predictive low glucose suspend (PLGS)

Aug 15 2017

BRIEF-Tandem Diabetes Care Q2 net loss per share $0.44

* Tandem Diabetes Care reports second quarter 2017 financial results

Jul 27 2017

BRIEF-Tandem Diabetes Care Q2 sales $21.3 million

* Tandem Diabetes Care reports second quarter 2017 financial results

Jul 27 2017

BRIEF-Tandem Diabetes Care reports Q1 loss per share $0.75

* Tandem Diabetes Care reports first quarter 2017 financial results

Apr 27 2017

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $142.40 +0.36
Roche Holding Ltd. (ROG.S) CHF234.40 -4.20
Roche Holding Ltd. (RO.S) CHF236.90 -4.80
Insulet Corporation (PODD.OQ) $61.58 -0.39

Earnings vs. Estimates